Press Releases
Samsung Biologics recognized by Newsweek as one of the 'World's Most Trustworthy Companies for 2023'
In the inaugural 'World's Most Trustworthy Companies 2023' list, published by Newsweek and data research firm Statista, Samsung Biologics ranked #2 in the Healthcare & Life Sciences industry category. The recognition reinforces the Company's unwavering commitment to excellence, quality, and the trust of its valued clients and partners.
As a dependable CDMO partner, Samsung Biologics has focused on enhancing a corporate culture where employees act on integrity to earn the trust of clients each and every day.
From an extensive survey of over 70,000 participants, companies were evaluated across different elements related to customer, investor, and employee trust. A total of 269,000 evaluations were submitted and the top 1,000 Most Trustworthy Companies across 23 industries were chosen based on a holistic approach to evaluating trust.
Samsung Biologics will continue to innovate and uphold its vision of delivering life-saving treatments by providing high-quality products, industry-leading services, and an unwavering responsibility to the communities in which it operates.
In the inaugural 'World's Most Trustworthy Companies 2023' list, published by Newsweek and data research firm Statista, Samsung Biologics ranked #2 in the Healthcare & Life Sciences industry category. The recognition reinforces the Company's unwavering commitment to excellence, quality, and the trust of its valued clients and partners.
As a dependable CDMO partner, Samsung Biologics has focused on enhancing a corporate culture where employees act on integrity to earn the trust of clients each and every day.
From an extensive survey of over 70,000 participants, companies were evaluated across different elements related to customer, investor, and employee trust. A total of 269,000 evaluations were submitted and the top 1,000 Most Trustworthy Companies across 23 industries were chosen based on a holistic approach to evaluating trust.
Samsung Biologics will continue to innovate and uphold its vision of delivering life-saving treatments by providing high-quality products, industry-leading services, and an unwavering responsibility to the communities in which it operates.